期刊文献+

儿童B细胞急性淋巴细胞白血病复发的危险因素分析

Analysis of Risk Factors for Relapse of B-cell Acute Lymphoblastic Leukemia in Children
暂未订购
导出
摘要 目的分析儿童B细胞急性淋巴细胞白血病(B-ALL)复发的危险因素。方法收集了2021年1月至2023年3月期间在医院就诊的81名患有B-ALL的患者纳入研究,为复发组(21人)和未复发组(60人)。比较两组的基本临床特点和白血病病例特点。使用Logistic回归分析B-ALL复发的相关因素。结果在21例复发B-ALL病例中,18例(85.71%)为单纯骨髓复发,2例(9.52%)为中枢神经系统复发,1例(4.76%)为睾丸复发。两组的年龄,化疗引起的白细胞减少时间(天)、新诊断时外周血白细胞计数、33天的最小残留病(MRD)和12周的MRD具有显著差异。因素Logistic回归分析结果发现年龄≥10岁(调整后OR=2.54,95%CI 1.14~5.23,P=0.002)、12周的MRD>10^(-4)(调整后OR=2.34,95%CI 1.53~5.21,P=0.001)为B-ALL患者复发的独立危险因素。结论儿童年龄≥10岁和12周的MRD>10^(-4)为B-ALL患者复发的独立危险因素。 Objective To analyze the risk factors for relapse of B-cell acute lymphoblastic leukemia(B-ALL)in children.Methods Eighty-one patients with B-ALL who attended the hospital between January 2021 and March 2023 were collected for inclusion in the study,as the relapsed group(21)and the non-relapsed group(60).Basic clinical characteristics and leukemia case characteristics were compared between the two groups.Factors associated with B-ALL relapse were analyzed using logistic regression.Results Of the 21 relapsed B-ALL cases,18(85.71%)were pure bone marrow relapses,2(9.52%)were central nervous system relapses,and 1(4.76%)was a testicular relapse.Age,duration of chemotherapy-induced leukopenia decreased(days),peripheral blood leukocyte count at new diagnosis,minimal residual disease(MRD)at 33 days and MRD at 12 weeks were significantly different between the two groups.Factor logistic regression analysis revealed that age≥10 years(adjusted OR=2.54,95%CI 1.14~5.23,P=0.002)and MRD>10^(-4) at 12 weeks(adjusted OR=2.34,95%CI 1.53~5.21,P=0.001)were found to be recurrence in patients with B-ALL independent risk factor for recurrence.Conclusion MRD>10^(-4) in children aged≥10 years and 12 weeks were independent risk factors for relapse in B-ALL patients.
作者 杨晓亭 黄彩娟 邱少佳 YANG Xiao-ting;HUANG Cai-juan;QIU Shao-jia(Department of Hematopathology,The First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,Henan Province,China)
出处 《罕少疾病杂志》 2025年第8期140-142,共3页 Journal of Rare and Uncommon Diseases
关键词 急性淋巴细胞白血病 儿童 复发 危险因素 最小残留病 Acute Lymphoblastic Leukemia Children Relapse Risk Factors Minimal Residual Disease
  • 相关文献

参考文献15

二级参考文献124

  • 1马晓莉,吴敏媛,胡亚美.婴儿急性白血病的生物学进展[J].临床血液学杂志,2005,18(4):247-250. 被引量:6
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:485
  • 3贾友超 竺晓凡.儿童急性淋巴细胞白血病复发的治疗.国际输血及血液学杂志,2008,31(2):167-167.
  • 4Basso G, Veltroni M, Valsecchi MG, et al. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cyto- metric measurement of residual disease on day 15 bone marrow. J Clin Oncol, 2009, 27:5 168-5174.
  • 5Irving J, Jesson J, Virgo P, et al. Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytome- try in a multi-center setting. Haematologica, 2009, 94:870-874.
  • 6Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted thera- py of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediat- ric and adolescent patients enrolled in the trialALL-BFM 95. Blood. 2008. 111:4477-4489.
  • 7Campana D. Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastieleukemia. Hematol Oncol Clin North Am, 2009, 23: 1083-1098.
  • 8Nyvold C, Madsen HO, Ryder LP, et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood ,2002,99 : 1253-1258.
  • 9Borowitz M J, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leu- kemia and its relationship to other prognostic factors: a Children' s Oncology Group study. Blood, 2008, 111 : 5477-5485.
  • 10Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual dis- ease-directed risk stratification using real-time quantitative PCR a- nalysis of immunoglobulin and T cell receptor gene rearrangements in the international multicenter trial AIEOPBFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 2008, 22: 771-782.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部